Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Non-invasive blood based monitoring of genomic alterations in cancer

Non-invasive blood based monitoring of genomic alterations in cancer

US Patent 10865451 · Granted Dec 15, 2020

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Pyrimidines as EGFR-inhibitors and methods of treating disorders2025
Degraders that target ALK and therapeutic uses thereof2025
Methods for evaluating tumor cell spheroids using 3D microfluidic cell culture d2024
Method to determine responsiveness of cancer to epidermal growth factor receptor2024
Inhibitors of EGFR and/or HER2 and methods of use2024
Denaturation-enhanced DNA mutation testing for limited biological specimens2024
Substituted 6,11-dihydro-5H-benzo[b]carbazoles as inhibitors of ALK and SRPK2024
Cyano quinoline amide compounds as HER2 inhibitors and methods of use2023
Pyrimidines as EGFR inhibitors and methods of treating disorders2023
Inhibitors of EGFR and methods of use thereof2023
Methods for evaluating tumor cell spheroids using 3D microfluidic cell culture d2023
Inhibitors of EGFR and/or HER2 and methods of use2021